160 related articles for article (PubMed ID: 25663100)
1. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
Noh JH; Lee MH; Kim WS; Lim DH; Kim ST; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2015 Apr; 157(4):569-76. PubMed ID: 25663100
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
Zhong S; Fu X; Wu C; Liu R; Li S
Neurosurg Rev; 2023 Nov; 46(1):311. PubMed ID: 37993665
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
Birzu C; Tran S; Bielle F; Touat M; Mokhtari K; Younan N; Psimaras D; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
Oncologist; 2020 Nov; 25(11):e1763-e1776. PubMed ID: 33394574
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract][Full Text] [Related]
8. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
9. Outcome of salvage treatment for recurrent glioblastoma.
Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact.
Kim H; Lim DH; Kim TG; Lee JI; Nam DH; Seol HJ; Kong DS; Choi JW; Suh YL; Kim ST
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e366-e373. PubMed ID: 29473335
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
12. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors.
Shinoura N; Tabei Y; Yamada R; Saito K; Takahashi M
J Neurooncol; 2008 May; 87(3):309-16. PubMed ID: 18074105
[TBL] [Abstract][Full Text] [Related]
14. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.
Fiorentino A; Caivano R; Chiumento C; Cozzolino M; Fusco V
Int J Neurosci; 2012 Nov; 122(11):691-4. PubMed ID: 22720749
[TBL] [Abstract][Full Text] [Related]
20. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
